These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [Role of the neutrophils in the pathogenesis of malignant growth]. Kashulina AP; Tereshchenko IP Eksp Onkol; 1985; 7(6):3-9. PubMed ID: 3910404 [TBL] [Abstract][Full Text] [Related]
28. [Cancer and immunity]. Nagel GA; Geiger C Schweiz Med Wochenschr; 1971 Nov; 101(45):1605-20. PubMed ID: 4947152 [No Abstract] [Full Text] [Related]
29. Escape from immune- and nonimmune-mediated tumor surveillance. Malmberg KJ; Ljunggren HG Semin Cancer Biol; 2006 Feb; 16(1):16-31. PubMed ID: 16140546 [TBL] [Abstract][Full Text] [Related]
30. Cancer and the immune system. Karakousis CP J Med; 1980; 11(5-6):449-58. PubMed ID: 6187876 [TBL] [Abstract][Full Text] [Related]
31. Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium. Vilien M Dan Med Bull; 1985 Aug; 32(4):199-218. PubMed ID: 3899526 [No Abstract] [Full Text] [Related]
34. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth. Takeda K; Smyth MJ; Cretney E; Hayakawa Y; Yamaguchi N; Yagita H; Okumura K Cell Immunol; 2001 Dec; 214(2):194-200. PubMed ID: 12088418 [TBL] [Abstract][Full Text] [Related]
35. [Why does a tumor grow?]. Dosne Pasqualini C; Laguens RP; Colmerauer ME; Segal A Medicina (B Aires); 1974; 34(6):659-64. PubMed ID: 4617837 [No Abstract] [Full Text] [Related]
36. Host resistance to cancer. Goldstein G Aust N Z J Surg; 1967 Feb; 36(3):238-42. PubMed ID: 5227488 [No Abstract] [Full Text] [Related]
37. Variation in histocompatibility antigen expression on murine tumors: differences in expression and immunogenicity of H-2K region-coded unique antigens. Imamura M; Martin WJ J Immunol; 1982 Aug; 129(2):877-81. PubMed ID: 7086147 [No Abstract] [Full Text] [Related]
38. Embryonic antigens in tumor immunity. Della Porta G Johns Hopkins Med J Suppl; 1974; 3():279-87. PubMed ID: 4138923 [No Abstract] [Full Text] [Related]
39. Clinical aspects of cancer immunity. Moore GE Prog Clin Cancer; 1973; 5():107-20. PubMed ID: 4571116 [No Abstract] [Full Text] [Related]
40. On the genesis and regulation of cellular heterogeneity in malignant tumors. Poste G; Greig R Invasion Metastasis; 1982; 2(3):137-76. PubMed ID: 6765249 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]